Doctor of Dentistry Program year 2024 Reported 2019–2024 Source: CMS Open Payments, 2026 publication

John Nale

Oral & Maxillofacial Surgery Charlotte, NC Doctor of Dentistry

NPI 1649475005 CMS profile 609439

411 Billingsley Rd, Suite 105, Charlotte, NC 28211

Open in the dashboard

General payments

$18,678

59 records reported · program years 2019–2024

Research payments

$0

Paid to them · None reported · program years 2019–2024

Ownership & investment interest

$0

None reported

Through program year 2024, John Nale of Charlotte, NC is reported in the CMS Open Payments database as having received $18,678 across 59 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 95th percentile of Oral & Maxillofacial Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2024 General $173 4
2023 General $468 3
2022 General $304 4
2021 General $16,176 16
2020 General $200 4
2019 General $1,357 28

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • John Nale
  • Oral & Maxillofacial Surgery median
  • Middle half of Oral & Maxillofacial Surgery
  • National median

In program year 2025, general payments to John Nale were reported at $0. Among 792 Oral & Maxillofacial Surgery profiles paid that year, the median was $184 and the middle half received between $61 and $541.

Show as a table
Year John Nale Oral & Maxillofacial Surgery median Middle half National median
2019 $1,357 $178 $56–$584 $163
2020 $200 $106 $38–$316 $114
2021 $16,176 $165 $57–$511 $132
2022 $304 $173 $63–$494 $149
2023 $468 $184 $62–$521 $160
2024 $173 $197 $65–$603 $164
2025 $0 $184 $61–$541 $169

Breakdown

Who paid General payments · program years 2019–2024
  1. Straumann USA LLC $16,020 13 payments
  2. Salvin Dental Specialties, Inc. $1,168 11 payments
  3. KLS-Martin L.P. $600 5 payments
  4. Dentsply Sirona Inc $382 15 payments
  5. Stryker Corporation $230 4 payments
  6. Zimmer Biomet Holdings, Inc. $94 5 payments
  7. DENTSPLY IH Inc. $72 2 payments
  8. Thommen Medical USA, LLC $43 1 payment
  9. Peerless Surgical Inc. $32 1 payment
  10. Geistlich Pharma, North America, Inc. $19 1 payment
  11. Other $18 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2024
  1. Gift $15,158 5 payments
  2. Food and Beverage $3,247 52 payments
  3. Travel and Lodging $236 1 payment
  4. Entertainment $37 1 payment
Products named General payments · program years 2019–2024
  1. ASTRA TECH Implant System $413 15 payments
  2. NA Craniomaxillofacial $105 1 payment
  3. NA Neuro $72 1 payment
  4. Tapered Screw Dental $57 3 payments
  5. SYMBIOS $54 1 payment
  6. ATLANTIS $54 1 payment
  7. CEREC $41 2 payments
  8. VSP SYSTEM, VSP CRANIAL $32 1 payment
  9. Tapered Screw Dental $22 1 payment
  10. UNIVERSAL NEURO 3 $21 1 payment
  11. Other $53 3 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 4 drugs

Part D claims

102

Median for Oral & Maxillofacial Surgery: 284

Drug cost

$362

Median for Oral & Maxillofacial Surgery: $1,067

Branded share of claims

51%

Median for Oral & Maxillofacial Surgery: 17.7%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 37 $181
Ondansetron Odt Ondansetron Brand 15 $81
Amoxicillin Generic 29 $57
Tramadol Hcl Generic 21 $43

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 600 Part D prescribers listed as Oral & Maxillofacial Surgery; they describe a distribution and say nothing about conduct.

Records

59 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Oral & Maxillofacial Surgery in North Carolina

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2024

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record